Annual Current Liabilities:
$87.78M-$21.01M(-19.31%)Summary
- As of today, CRSP annual current liabilities is $87.78 million, with the most recent change of -$21.01 million (-19.31%) on December 31, 2024.
- During the last 3 years, CRSP annual current liabilities has fallen by -$32.10 million (-26.78%).
- CRSP annual current liabilities is now -27.52% below its all-time high of $121.11 million, reached on December 31, 2022.
Performance
CRSP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$104.36M-$15.09M(-12.63%)Summary
- As of today, CRSP quarterly current liabilities is $104.36 million, with the most recent change of -$15.09 million (-12.63%) on June 30, 2025.
- Over the past year, CRSP quarterly current liabilities has dropped by -$23.46 million (-18.35%).
- CRSP quarterly current liabilities is now -30.83% below its all-time high of $150.87 million, reached on September 30, 2022.
Performance
CRSP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CRSP Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -19.3% | -18.4% |
| 3Y3 Years | -26.8% | -13.0% |
| 5Y5 Years | +53.7% | +40.1% |
CRSP Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -27.5% | at low | -30.8% | +18.9% |
| 5Y | 5-Year | -27.5% | +53.7% | -30.8% | +25.6% |
| All-Time | All-Time | -27.5% | +3990.5% | -30.8% | +927.7% |
CRSP Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $104.36M(-12.6%) |
| Mar 2025 | - | $119.45M(+36.1%) |
| Dec 2024 | $87.78M(-19.3%) | $87.78M(-2.3%) |
| Sep 2024 | - | $89.81M(-29.7%) |
| Jun 2024 | - | $127.82M(+7.4%) |
| Mar 2024 | - | $118.99M(+9.4%) |
| Dec 2023 | $108.79M(-10.2%) | $108.79M(-2.2%) |
| Sep 2023 | - | $111.23M(-16.3%) |
| Jun 2023 | - | $132.84M(-9.5%) |
| Mar 2023 | - | $146.79M(+21.2%) |
| Dec 2022 | $121.11M(+1.0%) | $121.11M(-19.7%) |
| Sep 2022 | - | $150.87M(+25.8%) |
| Jun 2022 | - | $119.96M(+5.5%) |
| Mar 2022 | - | $113.70M(-5.2%) |
| Dec 2021 | $119.88M(+27.2%) | $119.88M(+24.6%) |
| Sep 2021 | - | $96.21M(-3.7%) |
| Jun 2021 | - | $99.92M(+20.3%) |
| Mar 2021 | - | $83.09M(-11.8%) |
| Dec 2020 | $94.26M | $94.26M(+12.0%) |
| Sep 2020 | - | $84.15M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $74.50M(+35.3%) |
| Mar 2020 | - | $55.09M(-3.5%) |
| Dec 2019 | $57.11M(+105.8%) | $57.11M(-28.4%) |
| Sep 2019 | - | $79.78M(+154.0%) |
| Jun 2019 | - | $31.41M(+10.6%) |
| Mar 2019 | - | $28.40M(+2.3%) |
| Dec 2018 | $27.75M(+91.2%) | $27.75M(-14.0%) |
| Sep 2018 | - | $32.28M(+74.7%) |
| Jun 2018 | - | $18.48M(+28.4%) |
| Mar 2018 | - | $14.39M(-0.8%) |
| Dec 2017 | $14.51M(-34.0%) | $14.51M(+19.8%) |
| Sep 2017 | - | $12.12M(-23.4%) |
| Jun 2017 | - | $15.81M(-6.5%) |
| Mar 2017 | - | $16.91M(-23.1%) |
| Dec 2016 | $22.00M(+116.6%) | $22.00M(-71.8%) |
| Sep 2016 | - | $78.10M(-3.1%) |
| Jun 2016 | - | $80.60M(+6.3%) |
| Mar 2016 | - | $75.83M(+646.8%) |
| Dec 2015 | $10.15M(+373.2%) | $10.15M |
| Dec 2014 | $2.15M | - |
FAQ
- What is CRISPR Therapeutics AG annual current liabilities?
- What is the all-time high annual current liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual current liabilities year-on-year change?
- What is CRISPR Therapeutics AG quarterly current liabilities?
- What is the all-time high quarterly current liabilities for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly current liabilities year-on-year change?
What is CRISPR Therapeutics AG annual current liabilities?
The current annual current liabilities of CRSP is $87.78M
What is the all-time high annual current liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual current liabilities is $121.11M
What is CRISPR Therapeutics AG annual current liabilities year-on-year change?
Over the past year, CRSP annual current liabilities has changed by -$21.01M (-19.31%)
What is CRISPR Therapeutics AG quarterly current liabilities?
The current quarterly current liabilities of CRSP is $104.36M
What is the all-time high quarterly current liabilities for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly current liabilities is $150.87M
What is CRISPR Therapeutics AG quarterly current liabilities year-on-year change?
Over the past year, CRSP quarterly current liabilities has changed by -$23.46M (-18.35%)